T1D Exchange
Boston, Massachusetts, 02111, United States
Location status: Recruiting
NCT Number: NCT04629586
The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.
To participate, you will be asked to:
* Read and sign an online informed consent form * Take a survey describing specific demographic and type 1 diabetes management information * Update your information annually * Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data
Interested in participating?
Request InfoAll sexes
Observational
Boston, Massachusetts, 02111, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observational research study
Time frame: 10 years
Gather longitudinal data on disease, health status, and patient-reported outcomes of individuals living with type 1 diabetes. This will be achieved by presenting participants with annual questionnaires, tracking any changes in their responses over time.
Contact information is provided by the study sponsor or research team.
Julia Ravelson
CONTACT
Kelsie LaFerrier
CONTACT
T1D Exchange, United States
Other
Acronym: T1D Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05569525
Autoimmune Diseases, Diabetes
Florence, FI, Italy
View Trial DetailsNCT06203106
ALS, Adnexal Diseases
New York, United States
View Trial DetailsNCT05692778
Autoimmune Diseases, Cardiovascular Diseases
Gothenburg, Sweden
View Trial DetailsNCT04769167
Autoimmune Diseases, Cardiovascular Abnormalities
St Louis, Missouri, United States
View Trial Details